Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

BN82002

Catalog No. T4671Cas No. 396073-89-5
Alias CDC25 Phosphatase Inhibitor I

BN82002 (CDC25 Phosphatase Inhibitor I) is a synthetic inhibitor of CDC25 phophatases

BN82002

BN82002

Purity: 99.91%
Catalog No. T4671Alias CDC25 Phosphatase Inhibitor ICas No. 396073-89-5
BN82002 (CDC25 Phosphatase Inhibitor I) is a synthetic inhibitor of CDC25 phophatases
Pack SizePriceAvailabilityQuantity
1 mg$38In Stock
5 mg$89In Stock
10 mg$122In Stock
25 mg$222In Stock
50 mg$372In Stock
100 mg$556In Stock
1 mL x 10 mM (in DMSO)$98In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "BN82002"

Select Batch
Purity:99.91%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
BN82002 (CDC25 Phosphatase Inhibitor I) is a synthetic inhibitor of CDC25 phophatases
Targets&IC50
CDC25B2:3.9 μM, CDC25A:2.4 μM, CDC25C:5.4 μM, CDC25B3:6.3 μM, CDC25C-cat:4.6 μM
In vitro
The in vitro impact of BN82002 on the proliferation of various human tumor cell lines has been assessed, with menadione serving as a control due to its documented proliferation inhibitory properties. All tested cell lines exhibit sensitivity to both BN82002 and menadione, demonstrating concentration-dependent inhibition within the low micromolar range. Among these, the pancreatic cancer cell line MIA PaCa-2 is the most affected by BN82002, showing an IC50 of 7.2 μM, while the colon cancer cell line HT-29 shows the least sensitivity with an IC50 of 32.6 μM. This range of inhibitory concentration for BN82002 closely matches that observed with menadione (5-15 μM). Further findings indicate that a 50 μM concentration of BN82002 completely halts cell proliferation. Although the influence on cell cycle distribution is relatively mild, there is a noted decrease in the S phase and an increase in cells with G1 and G2 DNA content, hinting at cell cycle arrest at various stages due to BN82002 treatment.
AliasCDC25 Phosphatase Inhibitor I
Chemical Properties
Molecular Weight359.42
FormulaC19H25N3O4
Cas No.396073-89-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 150 mg/mL (417.34 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7823 mL13.9113 mL27.8226 mL139.1130 mL
5 mM0.5565 mL2.7823 mL5.5645 mL27.8226 mL
10 mM0.2782 mL1.3911 mL2.7823 mL13.9113 mL
20 mM0.1391 mL0.6956 mL1.3911 mL6.9557 mL
50 mM0.0556 mL0.2782 mL0.5565 mL2.7823 mL
100 mM0.0278 mL0.1391 mL0.2782 mL1.3911 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BN82002 | purchase BN82002 | BN82002 cost | order BN82002 | BN82002 chemical structure | BN82002 in vitro | BN82002 formula | BN82002 molecular weight